LOT 1 - 22,000 BT Ceftriaxone Sodium for Injection
About This Opportunity
TranslatedThis tender concerns Lot 1, specifically the procurement of 22,000 bottles of Ceftriaxone Sodium for Injection, totaling 60,000,000 units. This is part of a larger framework agreement (DBS) for pharmaceuticals. The stated quantities represent projected needs over the duration of the agreement, with specific forecasts for 2021. It is important to note that additional active ingredients may be procured through separate tenders. Furthermore, existing framework agreements for Antibiotics, Antidotes, Corticoids, Narcotics, Analgesics, and Anticoagulants, scheduled to end on December 31, 2021, are intended to be integrated into this current framework agreement effective January 1, 2022.
The tender also lists anticipated requirements for other drug categories. Under 'Cardiology,' specific items include Adenosine Injection (total need approx. 31,010 ampoules), Amlodipine Tablets (total need approx. 907,000 units), Cafedrine and Theodrenaline Hydrochloride Injection (total need approx. 111,002 ampoules), Candesartan Cilexetil Tablets (total need approx. 1,730,176 units), Metoprolol Succinate Extended-Release Tablets (total need approx. 481,540 units), Ramipril Tablets 2.5 mg (total need approx. 804,180 units), and Ramipril Tablets 10 mg (total need approx. 168,200 units).
Under 'Antiemetics,' requirements include Dimenhydrinate Injection (62 mg, total need approx. 31,220 ampoules), Dimenhydrinate Injection (100 mg with Benzyl Alcohol 105 mg, total need approx. 17,524 ampoules), Dimenhydrinate Tablets (50 mg, total need approx. 1,700,000 units), and Ondansetron Hyd...
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Germany, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: German60.000.000 Einheiten (Units) Es ist beabsichtigt im Rahmen des DBS beispielsweise die nachfolgenden Arzneimittel unter Vertrag zu bringen. Die angegebenen Mengen (Gesamtzeit = Laufzeit des DBS; Bedarf 2021 = voraussichtlicher Jahresbedarf 2021) stellen jeweils Prognosewerte dar. Es wird ausdrücklich darauf hingewiesen, dass weitere Wirkstoffe durch Einzelvergaben platziert werden können. Darüber hinaus ist vorgesehen, das DBS Antibiotika und das DBS Antidota, Corticoide, Narkotika, Analgetika und Antikoagulantia zum 31.12.2021 vorzeitig zu beenden und zum 01.01.2022 in das hier gegenständliche DBS zu überführen Legende: AM = Ampulle, EA = Stück, TU = Tube, BT = Bottle, TBL = Tablette, IE = Internationale Einheit Kardiaka 1. ADENOSIN INJEKTION (Wirkstoff ADENOSIN 6 MG/2ML), Gesamtbedarf ca. 31.010 AM, Bedarf 2021 ca. 30.210 AM, 2. AMLODIPIN TABLETTE (Wirkstoff AMLODIPIN 5 MG), Gesamtbedarf ca. 907.000 EA, Bedarf 2021 ca. 2.400 EA, 3. CAFEDRIN- UND THEODRENALINHYDROCHLORID INJEKTION (Wirkstoff 1 CAFEDRIN 200 MG, Wirkstoff 2 THEODRENALIN 10 MG), Gesamtbedarf ca. 111.002 AM , Bedarf 2021 ca. 47.562 4. CANDESARTANCILEXETIL-TABLETTEN (Wirkstoff CANDESARTAN 16 MG teilbar) Gesamtbedarf ca. 1.730.176 EA, Bedarf 2021 ca. 0 EA 5. METOPROLOLSUCCINAT-TABLETTEN MIT VERLAENGERTER FREISETZUNG (Wirkstoff METOPROLOL 39,91 MG teilbar) Gesamtbedarf ca. 481.540 EA, Bedarf 2021 ca. 5.100 EA 6. RAMIPRIL TABLETTE (Wirkstoff RAMIPRIL 2,5 MG), Gesamtbedarf ca. 804.180 EA , Bedarf 2021 ca. 0 EA 7. RAMIPRIL TABLETTE (Wirkstoff RAMIPRIL 10MG) Gesamtbedarf ca. 168.200 EA, Bedarf 2021 ca. 3.600 EA Antiemetika 1. DIMENHYDRINAT INJEKTION (Wirkstoff DIMENHYDRINAT 62 MG), Gesamtbedarf ca. 31.220 AM, Bedarf 2021 ca. 29.040 AM 2. DIMENHYDRINAT INJEKTION (Wirkstoff DIMENHYDRINAT 100 MG, Wirkstoff 2 BENZYLALKOHOL 105 MG) Gesamtbedarf ca. 17.524 AM, Bedarf 2021 ca. 12.000 AM 3. DIMENHYDRINAT-TABLETTEN (Wirkstoff DIMENHYDRINAT 50 MG) Gesamtbedarf ca. 1.700.000 EA, Bedarf 2021 ca. 1.940 EA 4. ONDANSETRONHYDROCHLORID INJEKTION (Wirkstoff ONDANSETRON 4 MG) Gesamtbedarf ca. 46.485 AM, Bedarf 2021 ca. 12.025 AM Ophthalmika 1. ACETAZOLAMID TABLETTE (Wirkstoff ACETAZOLAMID 250 MG) Gesamtbedarf ca. 93.930 EA, Bedarf 2021 ca. 90.130 EA 2. DEXPANTHENOL SALBE (Wirkstoff DEXPANTHENOL 50 MG) Gesamtbedarf ca. 157.132 TU, Bedarf 2021 ca. 27.930 TU 3. NATRIUMCHLORID-LOESUNG (Wirkstoff NATRIUMCHLORID 4,5 GM) Gesamtbedarf ca. 19.848 BT, Bedarf 2021 ca. 6.648 BT 4. OXYBUPROCAINHYDROCHLORID AUGENTROPFEN (Wirkstoff OXYBUPROCAIN 4 MG) Gesamtbedarf ca. 24.513 BT, Bedarf 2021 ca. 19.970 BT Dermatika 1. ACICLOVIR CREME (Wirkstoff ACICLOVIR 50 MG/G) Gesamtbedarf ca. 32.090 TU, Bedarf 2021 ca. 522 TU 2. DEXPANTHENOL AUGEN UND NASENSALBE (Wirkstoff DEXPANTHENOL 50 MG/G) Gesamtbedarf ca. 157.132 TU, Bedarf 2021 ca. 27.930 TU 3. FETTCREME ZUR BEHANDLUNG VON HAUTERKRANKUNGEN AUF TROCKENER HAUT (Wirkstoff FETTSAEUREN, UNGESAETTIGT 8,15 MG) Gesamtbedarf ca. 27.413 TU, Bedarf 2021 ca. 2.040 TU 4. Miconazol nitrat _Flupredniden Creme (Wirkstoff 1 MICONAZOL 1 MG, Wirkstoff 2 FLUPREDNIDEN 0,9 MG) Gesamtbedarf ca. 15.023 TU, Bedarf 2021 ca. 4.890 TU Magen-Darm-Therapeutika 1. LOPERAMIDHYDROCHLORID KAPSEL (Wirkstoff LOPERAMID 1,860 MG) Gesamtbedarf ca. 851.473 EA, Bedarf 2021 ca. 260.200 EA 2. MAGALDRAT SUSPENSION (Wirkstoff MAGALDRAT 1600 MG) Gesamtbedarf ca. 198.570 BG, Bedarf 2021 ca. 0 BG 3. PANTOPRAZOLNATRIUM TABLETTE (Wirkstoff PANTOPRAZOL NATRIUM-1,5-WASSER 45,110 MG) Gesamtbedarf ca. 7.512.528 EA, Bedarf 2021 ca. 46.020 EA 4. SIMETICON KAUTABLETTEN (Wirkstoff DIMETICON 40 MG) Gesamtbedarf ca. 274.260 EA, Bedarf 2021 ca. 0 EA Erkältung 1. CETYLPYRIDINIUMCHLORID UND BENZOCAIN LUTSCHTABLETTE (Wirkstoff 1 CETYLPYRIDINIUM 1,4 MG, Wirkstoff 2 BENZOCAIN 10 MG) Gesamtbedarf ca. 5.917.888 EA, Bedarf 2021 ca. 24.480 EA 2. MYRTOL KAPSELN (Wirkstoff MYRTOL 300 MG) Gesamtbedarf ca. 2.593.640 EA, Bedarf 2021 ca. 48.400 EA 3. ACETYLCYSTEIN TABLETTE (Wirkstoff ACETYLCYSTEIN 600 MG) Gesamtbedarf ca. 558.430 EA,...
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 11, 2025. Last refreshed 18 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr
Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr has issued 176 procurement notices on BidsFactory, including 18 currently open and 97 awarded contracts. Activity concentrates in Security, Defense & Justice, General Supplies & Services, and Transport & Logistics. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU) and DÖE Bekanntmachungsservice (Germany). Most recent publication: July 9, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Hikma Pharma GmbH. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.